The Oncology Translational Research (TR) Scientist Intern joins a team developing new therapeutics, biomarkers, and precision medicine strategies for oncology clinical trials. The internship is designed to give undergraduate and graduate students experience in pharmaceutical research and development and an understanding of the science and process of novel drug development. Interns may explore disease biology, identify therapeutic approaches and drug targets, investigate mechanisms of action, and study biomarkers of response and resistance. Students in computational biology may develop methods to analyze omics data for program-specific questions. Lab-based interns may train on relevant technology platforms and analytical methods, and may receive guidance in experimental planning, execution, and troubleshooting. The work may involve extensive collaboration with global, cross-functional colleagues. Interns are assigned a mentor and present their work to project teams and Oncology senior leadership. They also prepare and present a poster or abstract about their primary research project at the annual global summer intern research symposium. The internship is a full-time opportunity expected to last approximately 12 weeks, from May 10 through August 13, 2027. Non-lab-based interns follow a hybrid schedule, reporting onsite three days per week and working remotely two days per week.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Intern
Education Level
No Education Listed